⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ONCY News
Oncolytics Biotech, Inc. Common Shares
THE EFFICIENCY PARADOX: 5 Market Anomalies Trading Below Reality
globenewswire.com
ONCY
VWAV
UPDATE -- The Efficiency Gap: Five Assets Where Price Has Yet To Reflect Reality
globenewswire.com
ONCY
The Efficiency Gap: Five Assets Where Price Has Yet To Reflect Reality
globenewswire.com
ONCY
Oncolytics Biotech ® Provides Update on Special Meeting of Shareholders
businesswire.com
ONCY
Oncolytics Biotech ® Aligns with FDA on Pivotal Study Design for Pelareorep in First-Line Pancreatic Cancer
businesswire.com
ONCY
Oncolytics Biotech ® Establishes Gastrointestinal Tumor Scientific Advisory Board to Advance Pelareorep as a Platform Immunotherapy
businesswire.com
ONCY
Oncolytics Biotech® Reports Updated Anal Cancer Data Showing Objective Response Rate More Than Double the Current Standard of Care
prnewswire.com
ONCY
Oncolytics Biotech® Announces Update for Potential First-Line Pancreatic Cancer Registration Study
prnewswire.com
ONCY
Cancer Immunotherapy Surge Drives $258B Market as FDA Accelerates Approvals
prnewswire.com
ONCY
ANIX
ICCM
IBRX
REGN
ONCY
ANIX
ICCM
IBRX
REGN
Oncolytics Biotech® Provides Update on GOBLET Study Progress and U.S. Site Expansion
prnewswire.com
ONCY